The National Institute for Health and Care Research (NIHR) has announced a £157 million investment over 5 years to support 10 ...

Men with BRCA1 and BRCA2 gene mutations should be offered annual PSA testing from the age of 40 to detect prostate cancer at ...

Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro ...

Artificial intelligence tools that could revolutionise patient care are being trialled in phase 2 of the Medicines and ...

Enterome has received fast track designation from the US Food and Drug Administration for its lead OncoMimics immunotherapy EO2463, targeting follicular lymphoma in the low tumour burden ...

Eligible patients in Scotland with relapsed or refractory multiple myeloma will now have access to a new treatment option ...

Women in Scotland suffering from endometriosis now have access to a new treatment option following the Scottish Medicines ...

AbbVie has announced new clinical data from its antibody-drug conjugate (ADC) platform, reinforcing its commitment to ...

Kainos has announced a new contract of up to three years with NHS England to enhance digital preventative healthcare services ...

Under the agreement, Hikma will hold exclusive commercialisation rights in all MENA markets, while Celltrion will oversee ...

Herantis Pharma has announced positive topline results from its phase 1b trial of HER-096 in people living with Parkinson’s ...

Patients in the UK are set to benefit from a strengthened partnership between the Medicines and Healthcare products ...